eczema
Conditions
Interventions
experimental group:Compound Yinhualishi granules+Cetirizine+Single cream
control group:Placebo + Cetirizine + Single cream
Sponsors
Shanghai Skin Disease Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-65 years (including 18 and 65); 2. Meet the diagnostic standards of Western medicine and Chinese medicine for eczema; 3. Previous history of acute and subacute eczema; 4. All of them were primary eczema, which was not related to occupational factors; 5. Be informed of the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiovascular and cerebrovascular diseases, hematopoietic system, endocrine system diseases and liver and kidney insufficiency; 2. Patients who have been systematically treated with glucocorticoid, retinoic acid and immunosuppressant for nearly 1 month; 3. Patients with acute contact dermatitis, drug rash, urticaria and other allergic skin diseases; 4. Patients with malignant tumor, immune hypofunction and malnutrition; 5. Patients who are pregnant, breastfeeding or planning a pregnancy, or women of childbearing age who cannot use effective contraception during the trial period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analog scale of itching degree;Skin hydration;Epidermal water loss rate;Texture parameters;Regional renal blood flow; | — |
Countries
China
Contacts
Public ContactTai Zongguang
Shanghai Skin Disease Hospital
Outcome results
None listed